WDB Holdings Co., Ltd. To Acquire DZS Clinical Services

FOR IMMEDIATE RELEASE WDB Holdings Co., Ltd. Tokyo Stock Exchange code: 2475 Contact: Miki Otsuka Senior Managing Director +81-79-287-0111 Released on August 31, 2018, in Hyogo, Japan Announcement on Acquisition of 100% shares by a subsidiary in the US WDB Holdings Co., Ltd. announces that the Board of the Directors Meeting held on August 31st, 2018 resolved […]

WDB Holdings Co., Ltd. to Acquire DZS Software Solutions, Inc.

FOR IMMEDIATE RELEASE WDB Holdings Co., Ltd. Tokyo Stock Exchange code: 2475 Contact: Miki Otsuka Senior Managing Director +81-79-287-0111 Released on August 31, 2018, in Hyogo, Japan Announcement on Acquisition of 100% shares by a subsidiary in the US WDB Holdings Co., Ltd. announces that the Board of the Directors Meeting held on August 31st, 2018 […]

DZS Clinical Services to Launch Upgraded ClinPlus® 3.1 eClinical Software at Drug Information Association Annual Meeting

(Bound Brook, N.J.; June 14, 2016) — DZS Clinical Services, a global provider of clinical development and data analytic services, has announced that it will be launching its enhanced ClinPlus® 3.1eClinical software at the Drug Information Association Annual Meeting (DIA) in Philadelphia. The ClinPlus eClinical Platform combines electronic data capture, a clinical trial management system, […]

DZS Completes First Bahrain Industry Study; Expands Middle East Services

DZS was contracted over two years ago by SBI Pharmaceuticals to assist in the first Industry Sponsored study in Bahrain; a small island country in the Middle East. DZS provided project management, local monitoring, and biometrics support. The study evaluated 5-ALA and the effect on Bahraini patients with Type II Diabetes and was recently completed. […]